Search Results - "Farde, Lars"

Refine Results
  1. 1

    Nigrostriatal dopamine transporter availability in early Parkinson's disease by Fazio, Patrik, Svenningsson, Per, Cselényi, Zsolt, Halldin, Christer, Farde, Lars, Varrone, Andrea

    Published in Movement disorders (01-04-2018)
    “…ABSTRACT Background: The imaging of biomarkers for characterization of dopaminergic impairment in Parkinson's disease (PD) is useful for diagnosis, patient…”
    Get full text
    Journal Article
  2. 2

    Quantification of Blood Flow-Dependent Component in Estimates of Beta-Amyloid Load Obtained Using Quasi-Steady-State Standardized Uptake Value Ratio by Cselényi, Zsolt, Farde, Lars

    “…Longitudinal positron emission tomography (PET) imaging of beta-amyloid is used in basic research and in drug efficacy trials in Alzheimer's disease (AD)…”
    Get full text
    Journal Article
  3. 3

    Serotonin transporter availability in adults with autism—a positron emission tomography study by Andersson, Max, Tangen, Ämma, Farde, Lars, Bölte, Sven, Halldin, Christer, Borg, Jacqueline, Lundberg, Johan

    Published in Molecular psychiatry (01-05-2021)
    “…Impairments in social interaction and communication, in combination with restricted, repetitive behaviors and interests, define the neurodevelopmental…”
    Get full text
    Journal Article
  4. 4

    Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia by Nord, Magdalena, Farde, Lars

    Published in CNS neuroscience & therapeutics (01-04-2011)
    “…SUMMARY Antipsychotic drugs were introduced in the early 50s on the basis of clinical observations in patients with schizophrenia. Experimental studies later…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Brain neuroreceptor density and personality traits: towards dimensional biomarkers for psychiatric disorders by Farde, Lars, Plavén-Sigray, Pontus, Borg, Jacqueline, Cervenka, Simon

    “…Positron emission tomography has, for 30 years, been used in numerous case-control studies searching for hypothesized differences in the density of…”
    Get full text
    Journal Article
  7. 7

    Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain by Svensson, Jonas E., Schain, Martin, Plavén-Sigray, Pontus, Cervenka, Simon, Tiger, Mikael, Nord, Magdalena, Halldin, Christer, Farde, Lars, Lundberg, Johan

    Published in NeuroImage (Orlando, Fla.) (15-11-2019)
    “…[11C]raclopride is a well established PET tracer for the quantification of dopamine 2/3 receptors (D2/3R) in the striatum. Outside of the striatum the receptor…”
    Get full text
    Journal Article
  8. 8

    Low convergent validity of [11C]raclopride binding in extrastriatal brain regions: A PET study of within-subject correlations with [11C]FLB 457 by Freiburghaus, Tove, Svensson, Jonas E., Matheson, Granville J., Plavén-Sigray, Pontus, Lundberg, Johan, Farde, Lars, Cervenka, Simon

    Published in NeuroImage (Orlando, Fla.) (01-02-2021)
    “…Dopamine D2 receptors (D2-R) in extrastriatal brain regions are of high interest for research in a wide range of psychiatric and neurologic disorders…”
    Get full text
    Journal Article
  9. 9

    The correlative triad among aging, dopamine, and cognition: Current status and future prospects by Bäckman, Lars, Nyberg, Lars, Lindenberger, Ulman, Li, Shu-Chen, Farde, Lars

    “…The brain neuronal systems defined by the neurotransmitter dopamine (DA) have since long a recognized role in the regulation of motor functions. More recently,…”
    Get full text
    Journal Article
  10. 10

    High-resolution PET imaging reveals subtle impairment of the serotonin transporter in an early non-depressed Parkinson’s disease cohort by Fazio, Patrik, Ferreira, Daniel, Svenningsson, Per, Halldin, Christer, Farde, Lars, Westman, Eric, Varrone, Andrea

    “…Purpose The serotonin transporter (SERT) is a biochemical marker for monoaminergic signaling in brain and has been suggested to be involved inthe…”
    Get full text
    Journal Article
  11. 11

    D1-Dopamine Receptor Availability in First-Episode Neuroleptic Naive Psychosis Patients by Stenkrona, Per, Matheson, Granville J, Halldin, Christer, Cervenka, Simon, Farde, Lars

    “…Positron emission tomography studies examining differences in D1-dopamine receptor binding between control subjects and patients with schizophrenia have been…”
    Get full text
    Journal Article
  12. 12

    Performance evaluation of the small-animal nanoScan PET/MRI system by Nagy, Kálmán, Tóth, Miklós, Major, Péter, Patay, Gergely, Egri, Gyozo, Häggkvist, Jenny, Varrone, Andrea, Farde, Lars, Halldin, Christer, Gulyás, Balázs

    Published in Journal of Nuclear Medicine (01-10-2013)
    “…nanoScan is a high-resolution integrated system for consecutive PET and MR imaging of small laboratory animals. We evaluated the performance of the system,…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Kinfitr — an open-source tool for reproducible PET modelling: validation and evaluation of test-retest reliability by Tjerkaski, Jonathan, Cervenka, Simon, Farde, Lars, Matheson, Granville James

    Published in EJNMMI research (08-07-2020)
    “…Background In positron emission tomography (PET) imaging, binding is typically estimated by fitting pharmacokinetic models to the series of measurements of…”
    Get full text
    Journal Article
  16. 16

    Application of cross-species PET imaging to assess neurotransmitter release in brain by Finnema, Sjoerd J., Scheinin, Mika, Shahid, Mohammed, Lehto, Jussi, Borroni, Edilio, Bang-Andersen, Benny, Sallinen, Jukka, Wong, Erik, Farde, Lars, Halldin, Christer, Grimwood, Sarah

    Published in PSYCHOPHARMACOLOGY (01-11-2015)
    “…Rationale This review attempts to summarize the current status in relation to the use of positron emission tomography (PET) imaging in the assessment of…”
    Get full text
    Journal Article Book Review
  17. 17

    Diurnal and seasonal variation of the brain serotonin system in healthy male subjects by Matheson, Granville J, Schain, Martin, Almeida, Rita, Lundberg, Johan, Cselényi, Zsolt, Borg, Jacqueline, Varrone, Andrea, Farde, Lars, Cervenka, Simon

    Published in NeuroImage (Orlando, Fla.) (15-05-2015)
    “…The mammalian circadian clock underlies both diurnal and seasonal changes in physiology, and its function is thought to be disturbed in both seasonal and…”
    Get full text
    Journal Article
  18. 18

    Effect of a single dose of escitalopram on serotonin concentration in the non-human and human primate brain by Nord, Magdalena, Finnema, Sjoerd J., Halldin, Christer, Farde, Lars

    “…Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed for treatment of psychiatric disorders. The exact mechanism underlying the clinical…”
    Get full text
    Journal Article
  19. 19

    Individual differences in the proneness to have flow experiences are linked to dopamine D2-receptor availability in the dorsal striatum by de Manzano, Örjan, Cervenka, Simon, Jucaite, Aurelija, Hellenäs, Oscar, Farde, Lars, Ullén, Fredrik

    Published in NeuroImage (Orlando, Fla.) (15-02-2013)
    “…Flow is a subjective experience of high but effortless attention, enjoyment, and low self-awareness that can occur during the active performance of challenging…”
    Get full text
    Journal Article
  20. 20

    Dopamine D1 receptors and age differences in brain activation during working memory by Bäckman, Lars, Karlsson, Sari, Fischer, Håkan, Karlsson, Per, Brehmer, Yvonne, Rieckmann, Anna, MacDonald, Stuart W.S, Farde, Lars, Nyberg, Lars

    Published in Neurobiology of aging (01-10-2011)
    “…Abstract In an fMRI study, 20 younger and 20 healthy older adults were scanned while performing a spatial working-memory task under two levels of load. On a…”
    Get full text
    Journal Article